Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Dai

Showing results (491-500 of 583) with videos related to

Pageof 59
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|April 13, 2011
Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenibHai-Liang Zhang, Yao Zhu, Chao-Fu Wang, et al.
Plos One|April 30, 2015
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate CancerGui-Ming Zhang, Chun-Yang Bao, Fang-Ning Wan, et al.
Journal of Ethnopharmacology|November 11, 2024
Synergistic effects of Lianhuaqingwen in combination with Oseltamivir and Baloxavir against seasonal influenza virus: In vitro and in vivo assessmentCheng Zhang, Manhua Yuan, Wenwan Rong, et al.
Asian Journal of Andrology|July 3, 2013
The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancerXiao-Jie Bian, Yao Zhu, Yi-Jun Shen, et al.
Asian Journal of Andrology|May 8, 2012
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohortYao Zhu, Jin-You Wang, Yi-Jun Shen, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 28, 2008
[Epidemiology of prostate cancer from three centers and analysis of the first-line hormonal therapy for the advanced disease]Chun-guang Ma, Ding-wei Ye, Chang-ling Li, et al.
Cancer Research|February 28, 2019
Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder CancerDalong Cao, Zihao Qi, Yangyang Pang, et al.
International Urology and Nephrology|September 4, 2012
Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomyHu-Yang Xie, Yao Zhu, Xu-Dong Yao, et al.
The Kaohsiung Journal of Medical Sciences|January 22, 2014
Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancerYi-Ping Zhu, Xu-Dong Yao, Shi-Lin Zhang, et al.
Clinical Genitourinary Cancer|October 13, 2012
c-KIT: potential predictive factor for the efficacy of sorafenib in metastatic renal cell carcinoma with sarcomatoid featureHai-Liang Zhang, Yao Zhu, Xiao-Jian Qin, et al.
Pageof 59

Showing results (491-500 of 583) with videos related to

Sort By:
Pageof 59
International Journal of Urology : Official Journal of the Japanese Urological Association|April 13, 2011
Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenibHai-Liang Zhang, Yao Zhu, Chao-Fu Wang, et al.
Plos One|April 30, 2015
MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate CancerGui-Ming Zhang, Chun-Yang Bao, Fang-Ning Wan, et al.
Journal of Ethnopharmacology|November 11, 2024
Synergistic effects of Lianhuaqingwen in combination with Oseltamivir and Baloxavir against seasonal influenza virus: In vitro and in vivo assessmentCheng Zhang, Manhua Yuan, Wenwan Rong, et al.
Asian Journal of Andrology|July 3, 2013
The effectiveness of the TAX 327 nomogram in predicting overall survival in Chinese patients with metastatic castration-resistant prostate cancerXiao-Jie Bian, Yao Zhu, Yi-Jun Shen, et al.
Asian Journal of Andrology|May 8, 2012
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohortYao Zhu, Jin-You Wang, Yi-Jun Shen, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 28, 2008
[Epidemiology of prostate cancer from three centers and analysis of the first-line hormonal therapy for the advanced disease]Chun-guang Ma, Ding-wei Ye, Chang-ling Li, et al.
Cancer Research|February 28, 2019
Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder CancerDalong Cao, Zihao Qi, Yangyang Pang, et al.
International Urology and Nephrology|September 4, 2012
Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomyHu-Yang Xie, Yao Zhu, Xu-Dong Yao, et al.
The Kaohsiung Journal of Medical Sciences|January 22, 2014
Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancerYi-Ping Zhu, Xu-Dong Yao, Shi-Lin Zhang, et al.
Clinical Genitourinary Cancer|October 13, 2012
c-KIT: potential predictive factor for the efficacy of sorafenib in metastatic renal cell carcinoma with sarcomatoid featureHai-Liang Zhang, Yao Zhu, Xiao-Jian Qin, et al.
Pageof 59